EEG profile of intravenous zolpidem in healthy volunteers

Psychopharmacology

Volumn 114, Issue 1, 1994, Pages 138-146

  Patat, A ^a   Trocherie, S ^b   Thebault, J J ^c   Rosenzweig, P ^a   Dubruc, C ^a   Bianchetti, G ^a   Court, L A ^b   Morselli, P L ^a  

^a SANOFI   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c Hopital de la Fondation Cognacq Jay   (France)

Author keywords

Clinical pharmacology; EEG; Healthy volunteers; Non benzodiazepine hypnotic; Psychopharmacology; Zolpidem

Indexed keywords

IMIDAZOPYRIDINE DERIVATIVE; PLACEBO; ZOLPIDEM;

AREA UNDER THE CURVE; ARTICLE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTROENCEPHALOGRAM; HICCUP; NAUSEA; PRIORITY JOURNAL; SLEEP; VISUAL DISORDER; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; ALPHA RHYTHM; BETA RHYTHM; CROSS-OVER STUDIES; DELTA RHYTHM; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMAN; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; MALE; PYRIDINES; SLEEP STAGES;

EID: 0028352053     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02245455     Document Type: Article

References (77)

1. Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats
2. High affinity (3H) zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors
3. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam
4. In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the ω1 (BZD1) subtype
5. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo
6. Clinical pharmacokinetics of zolpidem in various physiological and pathological conditions
7. Enhancement of GABAergic transmission by zolpidem an imidazopyridine with preferential affinity for type I benzodiazepine receptors
8. The effects of zolpidem on characteristics of normal human sleep
9. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra
10. Zolpidem (10 mg and 20 mg): hypnotic action and residual effects after a single bedtime dose
11. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling
12. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men
13. Relationship between plasma concentration and effect of midazolam after oral and intravenous administration
14. Effect of zolpidem during sleep on ventilation and cardiovascular variables in normal subjects
15. Distribution of central ω1 (benzodiazepine1) and ω2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H] flunitrazepam and the ω1 selective ligand [3H] zolpidem
16. Drug effects on the EEG of various species of laboratory animals
17. EEG studies of some benzodiazepine (BZD) and non-BZS anxiolytichypnotic drugs
18. Zolpidem, a novel nonbenzodiazepine hypnotic: neuropharmacoly and behaviourial effects
19. EEG profile of zolpidem: in imidazopyridine hypnotic agent
20. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam
21. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers
22. Cerebral electrometry. Quantitative EEG applied to human psychopharmacologiques
23. Quantitative EEG analysis and psychopharmacology
24. EEG and psychopharmacology
25. An objective classification of psychoactive drugs
26. Blood levels and electroencephalographic effects of diazepam and bromazepam
27. Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and time
28. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat
29. Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam and oxazepam
30. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam and placebo
31. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam
32. Development and critical evaluation of an objective procedure for the electroencephalographic classification of psychotropic drugs
33. An absolute must in clinicopharmacological research: pharmaco-electroencephalography, its possibilities and limitations
34. Zolpidem: a four week pilot polysomnographic study in patients with chronic sleep disturbances
35. Development of a classification rule for the electroencephalographic classification rule for four clinical therapeutic psychotropic drug classes with EEG power spectrum variables in human volunteers
36. Stanford Sleepiness Scale. Quantification of sleepiness: a new approach
37. Quantitative pharmaco electroencephalography
38. Effects of psychotropic drugs in qualitatively and quantitatively analyzed human EEG
39. Computer EEG profiles of anxiolytics (quantitative EEG in the development of new anxiolytics)
40. HZI system for EEG parametrization and classification of psychotropic drugs
41. Computer EEG drug data base in psychopharmacology and in drug development
42. A double-blind study comparing the efficacy and safety of a single bedtime dose of halazepam with clorazepate and placebo in anxious outpatients
43. Sleep spindle and delta changes during chronic use of a short acting and a long acting benzodiazepine hypnotic. Electroencephalogr
44. Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system
45. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem
46. Rebound insomnia and newer hypnotics
47. Receptors in the mechanism of action of zolpidem
48. Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential
49. Effects of zolpidem (10 and 20 mg), lormetazepam, triazolam and placebo on night sleep and residual effects during the day. Receptors involved in the mechanism of action of zolpidem
50. Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs
51. Pharmaco-electroencephalography: the value of quantified EEG in psychopharmacology
52. Reduction of reticulate neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors
53. The dose effects of zolpidem on the sleep of healthy normals
54. Effect of zolpidem on sleep in insomniac patients
55. Daytime residual effects of zolpidem: a review of available data
56. Hypnotic activity of an imidazopyridine (zolpidem)
57. Autoradiographic localization of [3H] zolpidem binding sites in the rats CNS: comparison with the distribution of [3H] flunitrazepam binding sites
58. A new look at short-acting hypnotics
59. Safety profile of zolpidem
60. Computer-analysed EEG and psychometric assessment of two new non-benzodiazepine tranquillizers in healthy volunteers
61. Aspects topographiques des rythmes rapides médicamenteux en topo-encephalographie quantitative
62. γ-Aminobutyric acidA receptor alpha-5 subunit creates novel type II benzodiazepine receptor pharmacology
63. Influence of recombinant GABAA receptor subunit composition on the allosteric modulators of GABA-gated Cl-currents
64. The use EEG in drug profiling
65. Quantitative EEG and performance after administration of brotizolam to healthy volunteers
66. Pharmacokinetic and dynamic with a new anxiolytic imidazopyridine alpidem utilizing EEG and psychometry
67. Investigation of the development of tolerance of the actions of zolpidem and midazolam
68. Further behaviourial evidence for the selective sedative action of zolpidem
69. Dose response effects of zolpidem in normal geriatric subjects
70. Rule for vigilance classification based on spontaneous EEG activity
71. Pharmacokinetics and metabolism of zolpidem in various animal species and in humans
72. The contribution of quantitative electroencephalography to the study of a new hypnotic: zolpidem
73. Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule
74. Effects of chronically administered zolpidem on the sleep of healthy insomniacs
75. Zolpidem and placebo: a study in general practice in patients suffering from insomnia